ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHUMBLINE ADVISERS | 93,037 | $4,291,796 | 0.01% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 19,027 | $877,716 | 0.00% |
| D. E. Shaw & Co., Inc. | 94,929 | $4,379,075 | 0.00% |
| VOYA INVESTMENT MANAGEMENT LLC | 76,396 | $3,524,148 | 0.00% |
| THRIVENT FINANCIAL FOR LUTHERANS | 37,950 | $1,751 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 101,672 | $4,690,129 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 64,446 | $2,973 | 0.00% |
| DekaBank Deutsche Girozentrale | 40,000 | $1,868 | 0.00% |
| FRANKLIN RESOURCES INC | 179,618 | $8,285,779 | 0.00% |
| Truvestments Capital LLC | 158 | $7,289 | 0.00% |
| Handelsbanken Fonder AB | 14,623 | $675 | 0.00% |
| Neuberger Berman Group LLC | 102,645 | $4,735,014 | 0.00% |
| Walleye Capital LLC | 19,864 | $916,326 | 0.00% |
| DnB Asset Management AS | 11,826 | $545,533 | 0.00% |
| NORTHERN TRUST CORP | 312,363 | $14,409,305 | 0.00% |
| CALDWELL SUTTER CAPITAL, INC. | 123 | $5,674 | 0.00% |
| BARCLAYS PLC | 102,141 | $4,711 | 0.00% |
| Citadel Advisors | 276,683 | $12,763,387 | 0.00% |
| Ensign Peak Advisors, Inc | 30,590 | $1,411,117 | 0.00% |
| Amundi | 127,992 | $5,972,107 | 0.00% |
External links
This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q2 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.